Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Cardoza George, Chief Financial Officer. Insider active across 2 companies, notably SOPHiA GENETICS SA. Cumulatively, 13 disclosures have been recorded. Breakdown: 1 buy · 7 sells. Total volume traded: €5.7m. History available since 2 June 2021. The latest transaction was filed on 6 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cardoza George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
169,230 shares@ US$40.39100.0% of flowCommon StockSEC:0001077183-21-000155:0
13 of 13 declarations
About Cardoza George
George Cardoza is the Chief Financial Officer and President of Pharma Services at SOPHiA GENETICS SA and NEOGENOMICS INC. In this role, he oversees the financial and strategic operations of both companies. Cardoza plays a key role in guiding financial strategy and managing resources to ensure growth and innovation. His expertise is essential for the success of both organizations.